Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

The effect of postoperative enoxaparin on risk for reoperative hematoma.

Pannucci CJ, Wachtman CF, Dreszer G, Bailey SH, Portschy PR, Hamill JB, Hume KM, Hoxworth RE, Kalliainen LK, Rubin JP, Pusic AL, Wilkins EG.

Plast Reconstr Surg. 2012 Jan;129(1):160-8. doi: 10.1097/PRS.0b013e318236215c.

2.

Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients.

Pannucci CJ, Dreszer G, Wachtman CF, Bailey SH, Portschy PR, Hamill JB, Hume KM, Hoxworth RE, Rubin JP, Kalliainen LK, Pusic AL, Wilkins EG.

Plast Reconstr Surg. 2011 Nov;128(5):1093-103. doi: 10.1097/PRS.0b013e31822b6817.

3.

Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction.

Liao EC, Taghinia AH, Nguyen LP, Yueh JH, May JW Jr, Orgill DP.

Plast Reconstr Surg. 2008 Apr;121(4):1101-7. doi: 10.1097/01.prs.0000302454.43201.83.

PMID:
18349626
4.

Inadequate Enoxaparin Dosing Predicts 90-Day Venous Thromboembolism Risk among Plastic Surgery Inpatients: An Examination of Enoxaparin Pharmacodynamics.

Pannucci CJ, Rockwell WB, Ghanem M, Fleming KI, Momeni A, Agarwal J.

Plast Reconstr Surg. 2017 Apr;139(4):1009-1020. doi: 10.1097/PRS.0000000000003159.

PMID:
28350685
5.

Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients.

Seruya M, Venturi ML, Iorio ML, Davison SP.

Plast Reconstr Surg. 2008 Dec;122(6):1701-8. doi: 10.1097/PRS.0b013e31818dbffd.

PMID:
19050522
6.

The timing of preoperative prophylactic low-molecular-weight heparin administration in breast reconstruction.

Keith JN, Chong TW, Davar D, Moore AG, Morris A, Gimbel ML.

Plast Reconstr Surg. 2013 Aug;132(2):279-84. doi: 10.1097/PRS.0b013e318295870e.

PMID:
23897327
7.

Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients.

Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW, Jaber RM, Hamill JB, Hume KM, Rubin JP, Neligan PC, Kalliainen LK, Hoxworth RE, Pusic AL, Wilkins EG.

J Am Coll Surg. 2011 Jan;212(1):105-12. doi: 10.1016/j.jamcollsurg.2010.08.018. Epub 2010 Nov 18.

8.

Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.

Pannucci CJ, Hunt MM, Fleming KI, Prazak AM.

Plast Reconstr Surg. 2017 Oct;140(4):815-822. doi: 10.1097/PRS.0000000000003692.

PMID:
28953735
9.

Enoxaparin venous thromboembolism prophylaxis in bariatric surgery: A best evidence topic.

Parker SG, McGlone ER, Knight WR, Sufi P, Khan OA.

Int J Surg. 2015 Nov;23(Pt A):52-6. doi: 10.1016/j.ijsu.2015.09.005. Epub 2015 Sep 21. Review.

10.

Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol.

Hachey KJ, Sterbling H, Choi DS, Pinjic E, Hewes PD, Munoz J, McAneny D, Tripodis Y, Fernando HC, Litle VR.

J Am Coll Surg. 2016 Jun;222(6):1019-27. doi: 10.1016/j.jamcollsurg.2015.12.003. Epub 2015 Dec 18.

PMID:
26775163
11.

Changing practice: implementation of a venous thromboembolism prophylaxis protocol at an academic medical center.

Pannucci CJ, Jaber RM, Zumsteg JM, Golgotiu V, Spratke LM, Wilkins EG.

Plast Reconstr Surg. 2011 Nov;128(5):1085-92. doi: 10.1097/PRS.0b013e31822b67ff.

12.

Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.

Yen SH, Lin PC, Kuo FC, Wang JW.

Biomed J. 2014 Jul-Aug;37(4):199-204. doi: 10.4103/2319-4170.125627.

13.

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, Iorio A, Brambilla G.

N Engl J Med. 1998 Jul 9;339(2):80-5.

14.

Venous thromboembolism prophylaxis in the massive weight loss patient: relative risk of bleeding.

Michaels J, Coon D, Mulvey CL, Rubin JP.

Ann Plast Surg. 2015 Jun;74(6):699-702. doi: 10.1097/SAP.0000000000000009.

PMID:
24727447
15.

Practice patterns in high-risk bariatric venous thromboembolism prophylaxis.

Pryor HI 2nd, Singleton A, Lin E, Lin P, Vaziri K.

Surg Endosc. 2013 Mar;27(3):843-8. doi: 10.1007/s00464-012-2521-z. Epub 2012 Oct 6.

PMID:
23052502
16.

Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.

Yoshida Rde A, Yoshida WB, Maffei FH, El Dib R, Nunes R, Rollo HA.

Ann Vasc Surg. 2013 Apr;27(3):355-69. doi: 10.1016/j.avsg.2012.06.010. Epub 2013 Jan 23. Review.

PMID:
23351997
17.

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.

Levitan B, Yuan Z, Turpie AG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM.

Vasc Health Risk Manag. 2014 Mar 26;10:157-67. doi: 10.2147/VHRM.S54714. eCollection 2014.

18.

Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery.

Hatef DA, Kenkel JM, Nguyen MQ, Farkas JP, Abtahi F, Rohrich RJ, Brown SA.

Plast Reconstr Surg. 2008 Jul;122(1):269-79. doi: 10.1097/PRS.0b013e3181773d4a.

PMID:
18594417
19.

Practical Guidelines for Venous Thromboembolism Prophylaxis in Free Tissue Transfer.

Ricci JA, Crawford K, Ho OA, Lee BT, Patel KM, Iorio ML.

Plast Reconstr Surg. 2016 Nov;138(5):1120-1131.

PMID:
27783014
20.

The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.

Steele KE, Canner J, Prokopowicz G, Verde F, Beselman A, Wyse R, Chen J, Streiff M, Magnuson T, Lidor A, Schweitzer M.

Surg Obes Relat Dis. 2015 May-Jun;11(3):672-83. doi: 10.1016/j.soard.2014.10.003. Epub 2014 Oct 23.

PMID:
25620436

Supplemental Content

Support Center